Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine.
Sallah
S
S
Wan
J Y
JY
D000328:Adult; D001323:Autoantibodies / Q000276:immunology*; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology*; D005260:Female; D006474:Hemorrhagic Disorders / Q000209:etiology*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D010314:Partial Thromboplastin Time; D014740:Vidarabine / Q000009:adverse effects* / Q000031:analogs & derivatives
D001323:Autoantibodies; D016898:Interferon-alpha; D005169:Factor VIII; D014740:Vidarabine; C024352:fludarabine